Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 1.694
-0.076 (-4.29%)
At close: Jul 23, 2026
Medivir AB Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 9.01 | 8.51 | 3.48 | 7.63 | 4.41 | 32.39 |
Revenue Growth | 151.28% | 144.14% | -54.36% | 73.16% | -86.39% | 58.56% |
Gross Profit Gross Profit Growth | -30.81 | -32.91 | -97.79 | -61.23 | -64.67 | -40.88 |
Operating Income Operating Income Growth | -88.97 | -92.97 | -128.07 | -92.75 | -88.61 | -64.4 |
Net Income Net Income Growth | -90.5 | -94.4 | -123.32 | -89.32 | -88.77 | -63.13 |
Earnings Per Share EPS Growth | -0.39 | -0.66 | -1.08 | -1.48 | -1.59 | -1.20 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Sweden Sweden Growth | - | 0.05 | 0.19 | 0.22 | 0.22 |
The Rest of The Nordic Countries The Rest of The Nordic Countries Growth | 0.15 | 0.12 | 0.19 | 0.19 | 0.32 |
The Rest of Europe The Rest of Europe Growth | 2.8 | 2.91 | 3.31 | 3.56 | 3.66 |
Elsewhere in The World Elsewhere in The World Growth | 5.56 | 0.41 | 0.37 | 0.44 | - |
Total Total Growth | 8.51 | 3.48 | 7.63 | 4.41 | 25.54 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 149.1 | 119.21 | 62.53 | 169.52 | 117.43 | 221.17 |
Total Debt Total Debt Growth | 6.4 | 8.39 | 11.07 | 13.54 | 15.51 | 14.02 |
Net Cash (Debt) Net Cash Growth | 142.7 | 110.82 | 51.46 | 155.98 | 101.92 | 207.15 |
Net Cash Growth | 426.57% | 115.36% | -67.01% | 53.04% | -50.80% | 287.06% |
Net Cash Per Share Net Cash Per Share Growth | 0.61 | 0.78 | 0.45 | 2.58 | 1.83 | 3.92 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -59.55 | -73.35 | -124.19 | -59.67 | -101.82 | -48.73 |
Capital Expenditures CapEx Growth | - | - | - | - | -0.38 | - |
Free Cash Flow Free Cash Flow Growth | -59.55 | -73.35 | -124.19 | -59.67 | -102.2 | -48.73 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | - | - | - | - | - | -126.20% |
Operating Margin | -987.89% | -1092.98% | -3675.95% | -1215.16% | -2010.16% | -198.80% |
Pretax Margin | -1004.89% | -1109.80% | -3539.52% | -1170.21% | -2013.73% | -193.18% |
Profit Margin | -1004.89% | -1109.81% | -3539.52% | -1170.21% | -2013.73% | -194.87% |
FCF Margin | -661.20% | -862.31% | -3564.61% | -781.67% | -2318.56% | -150.44% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 273.11 | 273.11 | 273.11 | 273.11 | 273.11 |
PS Ratio | 116.23 | 21.57 | 91.43 | 20.85 | 125.15 | 19.27 |